Skip to content

Effectiveness of Isometric vs. Eccentric Exercise in Chronic Achilles Tendinopathy

Effectiveness of Eccentric Exercise Compared to Isometric Exercise in Athletes With Chronic Achilles Tendinopathy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02732782
Enrollment
45
Registered
2016-04-11
Start date
2016-08-31
Completion date
2020-10-30
Last updated
2021-02-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tendinopathy

Keywords

Achilles tendon, isometric muscle training, competitive sports, strength training, eccentric exercise, isometric exercise, chronic condition, regeneration, tendon, tendon properties, tendinopathy, tendinosis, intervention, training load, high performance sports

Brief summary

This is a prospective single blinded randomised controlled trial with a 12-week intervention period and a half-year follow-up period. The main purpose is to determine the effects of isometric exercise on mechanical, morphological and functional tendon properties versus eccentric exercise in chronic Achilles tendinopathy.

Detailed description

This research project was funded by means of the Bundesinstitut für Sportwissenschaft based on a resolution of the German Federal Parliament.

Interventions

OTHERIsometric exercise
OTHEREccentric exercise

Sponsors

Charite University, Berlin, Germany
CollaboratorOTHER
Humboldt-Universität zu Berlin
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
20 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Chronic (3 months or more) condition of unilateral Achilles tendinopathy confirmed by a medical doctor based on ultrasound * age 18-60 * male * VISA-A Score of at least 80

Exclusion criteria

* bilateral tendinopathy * any systemic or inflammatory diseases (i. e. Diabetes, Arthritis) * surgery on lower extremities in the past * corticoid injections in the last 12 months

Design outcomes

Primary

MeasureTime frameDescription
Morphological tendon properties, Tendon vascularization levelAt baseline and 12 weeks afterEquipment Linear ultrasound (7.5 Megahertz (MHz), ESAOTE MyLab 60) Software Doppler Flow Image Analyser version 1.01 Vascularization level of the tendon via Color Doppler (CD) ultrasound CD signals will be estimated through the total number of coloured pixels within the area of interest (3x7 centimeters (cm) with the help of Software Doppler Flow Image Analyser version 1.01 (http://www.gtech.dk).
Morphological tendon properties, Tendon cross sectional area (CSA)At baseline and 12 weeks afterEquipment Magnetic resonance imaging (MRI) (0.25 T MR Scanner (Esaote, G-Scan, Italy), T1-Gewichtung, 3D HYCE (GR) Sequency, TR 10 ms, TE 5 ms, flip angle 80°, layer thickness 3 mm, 1 Anregung) Software OsiriX (Pixmeo SARL, Version 2.5.1., Schweiz) Tendon thickness / cross sectional area (CSA) in square millimeter (mm²) through MRI, manually outlined via Software OsiriX (Pixmeo SARL, Version 2.5.1., Schweiz). The mean value of three measurements of the same image will be used for analysis. In order to demonstrate local changes within the tendon, CSA will be shown in 10% intervals relative to the total length of the tendon.
Mechanical tendon properties, Tendon stiffnessAt baseline and 12 weeks afterEquipment Dynamometer (Biodex System 3, Medical Systems Inc., USA), optical motion capture system with eight cameras with a frequency of 250 Hertz (Hz) (Vicon Nexus, version 1.7.1., Vicon Motion Systems, UK), electromyography (Myon m320RX, Myon AG, Schweiz) and a linear ultrasound (7.5 Megahertz (MHz), ESAOTE MyLab 60) Tendon stiffness in Newton per mm (N/mm) with support of tendon force in Newton (N)
Mechanical tendon properties, ModulusAt baseline and 12 weeks afterEquipment Dynamometer (Biodex System 3, Medical Systems Inc., USA), optical motion capture system with eight cameras with a frequency of 250 Hertz (Hz) (Vicon Nexus, version 1.7.1., Vicon Motion Systems, UK), electromyography (Myon m320RX, Myon AG, Schweiz) and a linear ultrasound (7.5 Megahertz (MHz), ESAOTE MyLab 60) Modulus in Pascal (Pa) based on tendon stress (Pa) and tendon elongation in millimeter (mm)
Morphological tendon properties, Tendon lengthAt baseline and 12 weeks afterEquipment Magnetic resonance imaging (MRI) (0.25 T MR Scanner (Esaote, G-Scan, Italy), T1-Gewichtung, 3D HYCE (GR) Sequency, TR 10 ms, TE 5 ms, flip angle 80°, layer thickness 3 mm, 1 Anregung) Software OsiriX (Pixmeo SARL, Version 2.5.1., Schweiz) Tendon length im millimeter (mm) through MRI, manually outlined via Software OsiriX (Pixmeo SARL, Version 2.5.1., Schweiz).The mean value of three measurements of the same image will be used for analysis.

Secondary

MeasureTime frameDescription
Clinical functional scoreAt baseline, 12 weeks and six months afterVictorian Institute of Sport (VISA) - Achilles (A) questionnaire scores from 0 points to 100 points.
Interleukin 6 levelAt baseline and 12 weeks afterInterleukin 6 (IL- 6) detection in the blood plasma is measured in picogram per milliliter (pg/ml) unit.
Functional tendon properties, Ground contact timeAt baseline and 12 weeks afterDrop jumps and counter movement jumps on a three dimensional force plate (AMTI, BP400600-2000, 60x40 cm, 1000 Hz) Ground contact time is estimated through ground reaction forces (N or kN).
Functional tendon properties, Maximum jump heightAt baseline and 12 weeks afterDrop jumps and counter movement jumps on a three dimensional force plate (AMTI, BP400600-2000, 60x40 cm, 1000 Hz) Maximum jump height is estimated through the vertical impulse / component of the ground reaction force in Newton (N) or Kilo Newton (kN)
Pain level via Visual Analogue Scale (VAS)At baseline, 12 weeks and six months afterA Visual Analogue Scale (VAS) for pain reaching from 0mm to 100mm as part of the VISA - A questionnaire.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 12, 2026